In addition, inhibition of BACE1 increased ADAM10 cleavage of APP, but decreasing ADAM10 activity increased the risk of AD by increasing β-secretase cleavage of APP (Colombo et al., 2013). This evidence concerns the gene ADAM10 and Alzheimer disease.